1. Vella S, Schwartländer B, Sow SP, Eholie SP, Murphy RL. The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. AIDS. 2012;26(10):1231–41.
2. Montaner JSG, Reiss P, Cooper D, Vella S, Harris M, Conway B, Wainberg MA, Smith D, Robinson P, Hall D, Myers M, Lange JMA, For the INCAS Study Group. A randomized, double-blind trial comparing combinations of Nevirapine, Didanosine, and zidovudine for HIV-infected PatientsThe INCAS trial. JAMA. 1998;279(12):930–7.
https://doi.org/10.1001/jama.279.12.930
.
3. European AIDS Clinical Society Guidelines 2017. Version 8.2. Available:
http://www.eacsociety.org/files/guidelines_8.2-english.pdf
. Last accessed: 18 Aug 2017.
4. World Health Organization Consolidated Guidelines on the use of antiretroviral drugs for treating and preventing of HIV infection. Recomendations for a public approach. 2nd edition, 2016. Available:
http://apps.who.int/iris/bitstream/10665/208825/1/9789241549684_eng.pdf
Last accessed: 18 Aug 2017.
5. Società Italiana di Malattie Infettive e Tropicali (SIMIT). Linee guida italiane sull'utilizzo dei farmaci anti-retrovirali e sulla gestione diagnostico-clinica delle persone coinfezione da HIV. Available:
http://www.salute.gov.it/imgs/C_17_pubblicazioni_2545_allegato.pdf
. Last accessed: 18 Aug 2017.